TO: Lanham Frazier, Big S
FROM: Drs. Evan Siemann & Meenakshi Bhattacharjee, Rice University
DATE: 3-11-2025
RE: Untargeted metabolomics analyses of EARTI ™ microgreens
We analyzed the metabolites in arugula (Eruca vesicaria) microgreens grown in the EARTI ™ chamber and arugula microgreens bought at local grocery stores. Untargeted metabolomics simultaneously measures all detectable compounds in a sample (hundreds to thousands of compounds), determines the relative concentrations of each compound among the samples via differences in peak areas, and identifies each compound (if possible). However, it does not tell the absolute concentrations of compounds so it is not possible to determine the relative concentrations of different compounds, even in the same sample. But, it gives a comprehensive chemical profile that can be used to compare among samples.
Arugula was grown for seven days post planting in the EARTI ™ chamber. Then the arugula microgreens were cut at the base, ground in liquid nitrogen with a mortar and pestle, and stored at -80°C. Another set of microgreens were harvested two days later and processed the same way. Later, another set of seven day microgreens were grown and processed. Arugula microgreens were bought from HEB and Sprouts and processed the same way as the EARTI ™ samples. All the samples were shipped in a container of dry ice to Creative Proteonomics in Shirley, NY. Details of their chemical analysis methods are at the end of this report.
The data were analyzed at Rice University. First, the untargeted metabolomics data were processed to remove peaks that could not be assigned to a specific compound. Second, Principle Component Analysis (PCA) was used to examine the overall chemical composition of samples and to determine which samples had similar vs. distinct chemical compositions. This was done separately for data generated using positive vs. negative detector modes. Third, each chemical compound was tested to determine whether it differed in concentration between the EARTI ™ vs. commercial samples using ANOVAs. P-values were adjusted using sequential Bonferroni correction (alpha=0.05) to control for false discovery with the large number of tests being performed. Fourth, the ratios of concentrations of each compound in EARTI ™ vs.
commercial samples were examined to identify compounds that occurred in much higher concentrations in EARTI ™ vs. commercial samples. Finally, a literature search was conducted to determine effects on human health for compounds that were present in significantly higher concentrations in EARTI ™ vs. commercial samples.
Key findings were: 1) Arugula microgreens grown in EARTI ™ had chemical compositions that were distinct from those of arugula microgreens available at local grocery stores in Houston, TX. 2) A shorter time to harvest in EARTI ™ produced arugula microgreens that had consistent chemical composition. 3) Seventeen compounds were significantly elevated in EARTI ™ arugula microgreens vs. those bought at local grocery stores and ten were significantly lower in EARTI ™ samples. 4) Another three compounds were not significantly different between EARTI ™ samples vs. those bought in local grocery stores but were present at more than 100 times the concentration in EARTI ™ samples. 5) More chemical compounds were elevated in arugula microgreens grown in EARTI ™ than in those bought at local grocery stores. 6) Dipeptides were commonly elevated in EARTI ™ samples.
1
PCA: The overall chemical composition of the samples fell into three distinct groups (Figure 1). In these graphs, points closer to each other have more similar chemical compositions and points more distant from each other have more distinct chemical compositions. In these graphs, positive vs. negative on the axes is arbitrary. The key finding was that, the same three groups are found in both positive and negative detector mode data. One group is the commercial samples from grocery stores (“C1” – H2Organics bought from HEB, “C2” – BrightFresh bought from Sprouts). Another was the short time to harvest samples from
EARTI ™ (“T1” – planted 10/2/24 and harvested on 10/9/24; “T2” – planted 10/19/24 and harvested on
10/26/24). The longer time to harvest EARTI ™ sample was separate from the others (“T3” – planted 10/2/24 and harvested on 10/11/24). At harvest, the T3 sample seemed to have some microbial contamination based on appearance and odor. It is important to note that it is possible that different arugula varieties were grown in EARTI ™ vs. those for commercial samples which could contribute to the differences in their chemical compositions.
Figure 1 Chemical composition of arugula microgreen samples grown in EARTI ™ for 7 days (T1, T2) or 9 days (T3) along with commercial arugula microgreen samples (C1, C2). Numbers indicate the percent of variation explained by each axis.
2
ANOVAs: For examining which compounds contribute to these distinct chemical compositions, we restricted statistical analyses to only the shortterm EARTI ™ vs. commercial samples. After correcting for examining a large number of compounds (~1000 in total) with a sequential Bonferroni procedure, there were 27 compounds that differed significantly between EARTI ™ vs. commercial samples (Table 1). If T:C >1 (i.e., log[T/C]>0) then there is a higher concentration in EARTI ™ samples vs. commercial samples [rows in green] while T:C<1 means greater concentrations in commercial samples [rows in red].
Table 1. The relative concentrations of samples that differed significantly between arugula microgreens grown in EARTI ™ vs. those bought at local grocery stores. Mode = detector mode. CODE indicates the peak number. RT = retention time in minutes. MW = molecular weight. T:C is the ratio of the compound’s concentration in EARTI ™ vs. commercial samples.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mode |
CODE |
RT [min] |
MW |
Name |
Formula |
Chemical class |
T1 |
T2 |
C1 |
C2 |
T:C |
log(T/C) |
P-value |
|
Pos |
C4607 |
5.781 |
482.10372 |
Epigallocatechin 3'-glucuronide |
C21 H22 O13 |
flavonoid metabolite (glucuronidated catechin derivative) |
2.93 |
3.21 |
15.63 |
15.01 |
0.20 |
-0.70 |
0.0008 |
|
Pos |
C2300 |
4.027 |
302.0798 |
Hesperetin |
C16 H14 O6 |
flavanone (Flavonoid compound) |
40.28 |
52.08 |
195.99 |
209.74 |
0.23 |
-0.64 |
0.0033 |
|
Neg |
C2315 |
5.799 |
316.18906 |
Menthol-glucoronide |
C16 H28 O6 |
glucuronidated monoterpenoid (menthol metabolite) |
35.30 |
36.88 |
143.65 |
144.66 |
0.25 |
-0.60 |
<.0001 |
|
Pos |
C1197 |
1.371 |
216.12212 |
N-Acetyl-arginine |
C8 H16 N4 O3 |
acetylated amino acid derivative |
8.31 |
9.10 |
29.21 |
30.16 |
0.29 |
-0.53 |
0.0009 |
|
Neg |
C0762 |
5.705 |
212.06876 |
Vanillactic acid |
C10 H12 O5 |
phenolic acid derivative (vanillin metabolite) |
11.80 |
10.37 |
27.99 |
27.64 |
0.40 |
-0.40 |
0.0019 |
|
Neg |
C0243 |
1.496 |
143.05835 |
Trimethadione |
C6 H9 N O3 |
oxazolidinedione (anticonvulsant drug) |
211.74 |
237.03 |
534.53 |
521.89 |
0.42 |
-0.37 |
0.0022 |
|
Pos |
C0953 |
7.343 |
190.13572 |
Heptanophenone |
C13 H18 O |
aromatic ketone |
24.25 |
26.56 |
51.90 |
50.55 |
0.50 |
-0.30 |
0.0027 |
|
Neg |
C0452 |
5.208 |
173.10551 |
N-Acetylalloisoleucine |
C8 H15 N O3 |
acetylated amino acid |
79.84 |
83.04 |
164.46 |
162.99 |
0.50 |
-0.30 |
0.0005 |
|
Pos |
C2222 |
1.805 |
296.1007 |
Aspartyl-Tyrosine |
C13 H16 N2 O6 |
dipeptide |
220.97 |
219.63 |
357.96 |
359.49 |
0.61 |
-0.21 |
<.0001 |
|
Neg |
C3451 |
11.798 |
367.27253 |
3, 5-Tetradecadiencarnitine |
C21 H37 N O4 |
acylcarnitine |
18.51 |
18.39 |
27.84 |
27.71 |
0.66 |
-0.18 |
<.0001 |
|
Neg |
C3674 |
12.394 |
377.29326 |
Arachidonoyl Serinol |
C23 H39 N O3 |
N-acyl ethanolamine-related lipid |
48.90 |
50.82 |
22.48 |
22.82 |
2.20 |
0.34 |
0.0013 |
|
Pos |
C0543 |
0.992 |
155.06946 |
Histidine |
C6 H9 N3 O2 |
amino acid |
5543.75 |
5371.65 |
2100.90 |
1778.52 |
2.81 |
0.45 |
0.0027 |
|
Pos |
C0228 |
75 |
118.04519 |
5-Mercapto-2-pentanone |
C5 H10 O S |
thiol-containing ketone (organosulfur compound) |
437.92 |
405.21 |
144.53 |
148.87 |
2.87 |
0.46 |
0.0036 |
|
Pos |
C1075 |
2.88 |
205.07383 |
Indolelactic acid |
C11 H11 N O3 |
indole derivative (tryptophan metabolite) |
195.31 |
197.99 |
36.67 |
46.08 |
4.75 |
0.68 |
0.0010 |
|
Pos |
C0970 |
3.078 |
193.07731 |
3-(Butylsulfinyl)alanin |
C7 H15 N O3 S |
sulfoxide-containing amino acid derivative |
33.35 |
31.80 |
6.74 |
3.70 |
6.24 |
0.80 |
0.0039 |
|
Neg |
C0850 |
1.613 |
220.08815 |
Alanine-Methionine |
C8 H16 N2 O3 S |
dipeptide |
369.15 |
356.18 |
37.93 |
66.98 |
6.91 |
0.84 |
0.0026 |
|
Pos |
C3151 |
6.016 |
351.15815 |
Tryptophan-Phenylalanine |
C20 H21 N3 O3 |
dipeptide |
99.38 |
102.04 |
12.92 |
9.70 |
8.91 |
0.95 |
0.0005 |
|
Neg |
C1092 |
4.931 |
244.17847 |
epsilon-(Hexanoyl)lysine |
C12 H24 N2 O3 |
lipidated amino acid (N-acyl lysine derivative) |
3172.16 |
3370.09 |
360.59 |
271.79 |
10.35 |
1 |
0.0013 |
|
Neg |
C1158 |
2.408 |
248.11932 |
Valine-Methionine |
C10 H20 N2 O3 S |
dipeptide |
414.68 |
452.32 |
26.23 |
28.58 |
15.82 |
1.20 |
0.0021 |
|
Neg |
C0051 |
82 |
97.96737 |
Sulfate |
H2 O4 S |
inorganic anion |
50321.93 |
54319.42 |
2520.49 |
3845.39 |
16.44 |
1.22 |
0.0018 |
|
Neg |
C1884 |
4.865 |
296.11932 |
glycyclamide |
C14 H20 N2 O3 S |
peptidomimetic (amide derivative of glycine) |
66.79 |
73 |
5.70 |
3 |
20.48 |
1.31 |
0.0023 |
|
Neg |
C0682 |
1.613 |
202.13176 |
Alanylleucine |
C9 H18 N2 O3 |
dipeptide |
1463.15 |
1504.32 |
69.38 |
69.84 |
21.31 |
1.33 |
0.0002 |
|
Neg |
C2210 |
5.769 |
312.14787 |
Phenylalanylphenylalanine |
C18 H20 N2 O3 |
dipeptide |
135.68 |
137.11 |
6.81 |
3.27 |
27.05 |
1.43 |
0.0002 |
|
Neg |
C1157 |
2.886 |
248.11931 |
6-Hydroxymelatonin |
C13 H16 N2 O3 |
melatonin metabolite (indole derivative) |
131.54 |
122.38 |
4.66 |
2.91 |
33.55 |
1.53 |
0.0014 |
|
Pos |
C4617 |
3.873 |
484.1117 |
Sulforaphane-glutathione |
C16 H28 N4 O7 S3 |
organosulfur compound (glutathione conjugate of sulforaphane) |
53.07 |
56.96 |
1.94 |
1.24 |
34.53 |
1.54 |
0.0014 |
|
Neg |
C1323 |
3.956 |
262.13489 |
Methionylleucine |
C11 H22 N2 O3 S |
dipeptide |
295.33 |
322.37 |
10.05 |
7.83 |
34.54 |
1.54 |
0.0020 |
|
Pos |
C1948 |
1.482 |
278.09354 |
N-Glutamylcysteine ethyl ester |
C10 H18 N2 O5 S |
glutathione precursor (modified dipeptide) |
|
61.76 |
1.71 |
1.63 |
38.25 |
1.58 |
0.0012 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3
Relative concentrations by sample: Although they are not significantly different between EARTI ™ and commercial samples, three compounds were present at more than 100 times the concentration in EARTI ™ vs. commercial samples. They were N-Butylbenzenesulfonamide (sulfonamide) which was ~200 times higher in EARTI ™ samples along with p-methoxybenzylisothiocyanate (isothiocyanate) and 2,3Dihydroxypropyl nonadecanoate (fatty acid ester) which were ~100 times higher in EARTI ™ samples.
Figure 2. The relative concentrations compounds (log transformed) in arugula microgreens grown in EARTI ™ [7 days] vs. those bought at local grocery stores.
4
Compound functions: Potential effects on human health for compounds that were present at significantly higher concentrations or at more than 100 times the concentration in arugula microgreens grown in EARTI ™ vs. those bought at local grocery stores (Table 2). It is important to note that untargeted metabolomics analysis does not tell the absolute concentrations of chemical compounds. Rather it tells the relative amounts of a particular compound in different samples. Therefore, a chemical compound may be present at very different concentrations in different samples but the concentrations may be too low to have any effects on human health. In addition, a chemical compound may be present at very different concentrations in different samples but those concentrations may have similar effects on human health. In order to link relative concentrations to human health, it would be necessary to conduct additional, quantitative, targeted chemical analyses. Nevertheless, most dipeptides that differed in concentration between EARTI ™ and commercial samples were higher in EARTI ™ samples. Higher dipeptide content in plants is considered beneficial from a health perspective as they are readily absorbed by the body compared to proteins and possess various health promoting properties.
Table 2: Potential effects of compounds elevated in EARTI ™ arugula microgreen samples vs. those bought in local grocery stores.
|
Name |
Potential effects on human health |
|
Arachidonoyl Serinol |
Neuroprotective, Improves motor function, Vasodilation of abdominal aorta. |
|
Histidine |
Improves cognitive function, growth& repair of damaged tissue, precursor of carnosine for human muscle and parts of brain, proton buffering, and histaminergic reactions |
|
5-Mercapto-2-pentanone |
Potentially hazardous material causes irritation of skin and respiratory tract. |
|
Indole lactic acid |
Anti-inflammatory, maintains healthy gut, protects intestinal inflammation cancer prevention |
|
3-(Butyl sulfinyl)alanine |
Strong Antioxidant Properties |
|
Alanine-Methionine |
Improves protein synthesis, strong antioxidants, modifies DNA, energy production, improves exercise performance, strengthens the immune system. |
|
Tryptophan-Phenylalanine |
Mood regulation, improves cognitive function, improves sleep quality, reduces stress. |
|
Epsilon-(Hexanoyl)lysine |
Very new oxidative stress marker |
|
Valine-Methionine |
Helps muscle growth, Tissue repair, Over all metabolic function, energy production, emotional stability, liver protection. |
|
Sulfate |
Liver protection, helps in digestion, building proteins, detoxification of body. |
|
Glycyclamide |
Strong antihyperglycemic activity |
|
Alanyl leucine |
Promotes muscle growth and repair, ,blood sugar regulation and Cognitive function. |
|
Phenylalanyl phenylalanine |
Helps with mood, pain and skin conditions, protein synthesis, Risk: Phenylketonuria |
|
6-Hydroxymelatonin |
Potential antioxidant properties, anti-inflammatory and neuroprotective properties, sleep regulator. |
|
Sulforaphane-glutathione |
Precursor of glutathione, cancer prevention, anti-inflammatory, detoxification, helps with hormonal imbalance. |
|
Methionyl leucine |
Helps with tissue growth, muscle repair, improves liver damage, mineral absorption, immune system boosts up and wound healing. |
|
N-Glutamyl cysteine ethyl ester |
Precursor for glutathione, crucial antioxidant, supports liver health, improves brain function, neuroprotective. |
|
2,3dihydroxypropyl nonadeconate |
Treating obesity related diseases, diabetes and inflammation. |
|
N-butylbenzenesulphonamide |
Bacteriostatic antimicrobials |
|
p-methoxybenzyl isothiocyanate |
Anti-inflammatory, antioxidant anticancer properties, generally found in cruciferous plants. |
5
1. Sample Information
5 plant samples for untargeted metabolomics analysis in the collected samples by UPLC-MS.
2.1 Instruments and reagents
Vanquish Flex UPLC combined with Q Exactive plus MS (Thermo)
ACQUITY UPLC HSS T3 (100×2.1 mm×1.8 μm)
Temp functional Centrifugation (Eppendorf)
Acetonitrile (Merck)
Methanol (Merck)
Formic acid (Merck)
2.2 Sample preparation
All samples were thawed and lyophilized, weigh about 100 mg of each sample and 800 μL 80% methanol, two 5-mm metal balls into tube. All samples were ground 180 s at 65 Hz, twice, followed by sonication for 30 min, 4°C. Then each sample was kept at -20°C for 1 h, vortexed for 30 s, and centrifuge 10 min at 12,000 rpm, 4°C. Finally, transfer 200 μL of supernatant and add 5 μL of 0.14 mg/mL DL-o-Chlorophenylalanine into vial, filtered through a 0.22 μm filter for LC-MS analysis.
Separation is performed by Vanquish Flex UPLC combined with Q Exactive plus (Thermo) which is equipped with a heated ESI source. A waters T3 column (100×2.1 mm×1.8 μm) was used for LC separation and the mobile phase is composed of solvent A (0.05% formic acid water) and solvent B (acetonitrile) with a gradient elution (0-1 min, 5% B; 1-12.5 min, 5%-95% B; 12.5-13.5 min, 95% B; 13.5-13.6 min, 95%-5% B; 13.6-16 min, 5% B). The flow rate of the mobile phase is 0.3 mL/min. The column temperature is maintained at 40°C, and the sample manager temperature is set at 4°C.
Mass spectrometry parameters in ESI+ and ESI- mode are listed as follows:
ESI+: Heater Temp 300°C; Sheath Gas Flow rate, 45 arb; Aux Gas Flow Rate, 15 arb; Sweep Gas Flow Rate, 1 arb; spray voltage, 3.0 KV; Capillary Temp, 350°C; S-Lens RF Level, 30%.
ESI-: Heater Temp 300°C, Sheath Gas Flow rate, 45 arb; Aux Gas Flow Rate, 15 arb; Sweep Gas Flow Rate, 1 arb; spray voltage, 3.2 KV; Capillary Temp,350°C; S-Lens RF Level,60%.
The results are shown in the excel sheet.